financetom
Business
financetom
/
Business
/
Market Chatter: Senator Warren Criticizes Regulators' Potential Leverage Rule Changes for Banks
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Senator Warren Criticizes Regulators' Potential Leverage Rule Changes for Banks
Jun 24, 2025 8:07 AM

10:43 AM EDT, 06/24/2025 (MT Newswires) -- US Senator Elizabeth Warren has criticized banking regulators' potential changes to the enhanced supplementary leverage ratio for banks, Bloomberg reported Tuesday, citing a letter that the lawmaker wrote to the regulators.

The changes, which include cutting a bank holding company's capital requirement under the rule to a 3.5% to 4.5% range from the current 5%, are set to be proposed after concerns that the rule constrained Treasuries market trading, the report said.

"It would be irresponsible to slash the eSLR in any economic environment," Warren said in the letter to Federal Reserve Vice Chair for Supervision Michelle Bowman, acting Federal Deposit Insurance Corp. chair Travis Hill and acting Office of the Comptroller of the Currency head Rodney Hood, according to the report. "It is especially reckless to do so given the numerous threats to the economy and the nation's financial system."

The FDIC declined to comment when contacted by MT Newswires, while Warren, the Fed and the OCC didn't immediately respond to requests for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 47.00, Change: +0.70, Percent Change: +1.50

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Alvotech Says European Commission Approved Mynzepli to Treat Retinal Diseases
Alvotech Says European Commission Approved Mynzepli to Treat Retinal Diseases
Aug 21, 2025
05:29 AM EDT, 08/21/2025 (MT Newswires) -- Alvotech ( ALVO ) and UK-based Advanz Pharma said Thursday that their Mynzepli fusion protein was approved by the European Commission to treat retinal diseases, including neovascular age-related macular degeneration. The companies said the approval was based on non-clinical and clinical similarity data, which included a confirmatory efficacy study comparing Mynzepli with Bayer's...
Chinese cosmetics firm Yatsen Q2 revenue rises
Chinese cosmetics firm Yatsen Q2 revenue rises
Aug 21, 2025
Overview * Yatsen Q2 2025 rev rises 36.8% yr/yr to RMB1.09 bln * Net loss narrows 77.2% to RMB19.5 mln, non-GAAP net income positive * Gross margin improves to 78.3%, driven by higher-margin product sales Outlook * Yatsen expects Q3 2025 net revenues between RMB778.6 mln and RMB880.1 mln * Company forecasts Q3 2025 revenue growth of 15% to 30%...
Yatsen Reports Q2 Adjusted Earnings, Higher Revenue; Q3 Sales Outlook Set
Yatsen Reports Q2 Adjusted Earnings, Higher Revenue; Q3 Sales Outlook Set
Aug 21, 2025
05:25 AM EDT, 08/21/2025 (MT Newswires) -- Yatsen Holding ( YSG ) reported Q2 non-GAAP earnings Thursday of 0.13 Chinese renminbi ($0.02) per diluted American depositary share, swinging from a loss of 0.67 renminbi a year earlier. Analyst estimates were not readily available for comparison. Net revenue for the quarter ended June 30 was 1.09 billion renminbi, compared with 794.5...
Johnson & Johnson to invest $2 billion to boost US manufacturing as drug tariffs loom
Johnson & Johnson to invest $2 billion to boost US manufacturing as drug tariffs loom
Aug 21, 2025
(Reuters) -Johnson & Johnson ( JNJ ) committed to invest $2 billion in North Carolina on Thursday to expand the drugmaker's U.S. manufacturing presence as potential drug import duties from President Donald Trump's administration loom. J&J said it plans to build a new facility at Tokyo-based Fujifilm Diosynth's manufacturing site in Holly Springs, North Carolina, over the next 10 years....
Copyright 2023-2026 - www.financetom.com All Rights Reserved